|
Market Closed -
Toronto S.E.
15:42:34 2026-10-20 EDT
|
5-day change | 1st Jan Change | ||
| 31.43 CAD | +2.01% |
|
+5.43% | +24.28% |
| 10-19 | Gilead Sciences, Inc. Presents New Findings From Its HIV And Antiviral Research And Development Programs At IDWeek 2026 | CI |
| 10-19 | Gilead's pill succeeds in mid-stage bowel disease trial | RE |
Main competitors
| Change | 5-day change | 1-month change | 3-month change | YTD change | 1-year change | 3-year change | 5-year change | 10-year change | Capi.($) | ||
|---|---|---|---|---|---|---|---|---|---|---|---|
 | +3.49% | +10.04% | +11.34% | +11.92% | +19.45% | +58.68% | +119.56% | +426.69% | +1,530.25% | 1,106B | |
| +2.19% | +4.32% | -3.94% | +4.24% | +25.32% | +33.88% | +69.52% | +58.36% | +125.79% | 612B | |
| +2.26% | +5.37% | +9.52% | +14.09% | +26.52% | +24.57% | +97.69% | +166.65% | +368.07% | 500B | |
| +2.58% | +8.37% | +9.28% | +17.55% | +18.80% | +38.71% | +63.14% | +10.70% | +67.70% | 367B | |
| +3.25% | +4.45% | +0.97% | +19.21% | +40.89% | +71.80% | +44.44% | +82.93% | +139.50% | 354B | |
| +1.85% | +6.04% | +9.90% | +2.76% | +15.42% | +21.47% | +49.17% | +62.76% | +68.22% | 286B | |
| +1.76% | +6.07% | +0.94% | +1.92% | -8.50% | +0.43% | +20.98% | +43.91% | +153.50% | 256B | |
| +3.29% | +6.32% | +13.82% | +20.53% | +34.11% | +44.71% | +57.43% | +109.36% | +171.79% | 230B | |
| +2.25% | +5.81% | +4.26% | +17.49% | +27.51% | +27.13% | +101.17% | +134.09% | +110.62% | 190B | |
| +1.83% | +1.77% | -7.23% | -20.37% | -19.69% | -27.40% | -61.46% | -21.64% | +87.78% | 170B | |
| +2.28% | +6.13% | +8.86% | +21.66% | +20.92% | +21.95% | -1.76% | -29.65% | -7.47% | 168B | |
| +2.53% | +6.07% | +1.24% | +7.11% | +13.52% | +22.80% | +42.22% | +177.45% | +520.66% | 127B | |
| +4.84% | +8.84% | -2.19% | +2.53% | +14.35% | +41.50% | +9.25% | +6.22% | +22.48% | 120B | |
| +1.95% | +7.09% | +17.78% | +23.89% | +25.58% | +30.76% | +127.49% | +399.84% | +536.07% | 118B | |
| +0.73% | +6.59% | -0.48% | -0.72% | +2.41% | +14.39% | +27.80% | +6.15% | -10.25% | 99B | |
| +3.62% | +4.01% | -0.63% | -4.33% | -11.05% | -15.02% | -25.55% | -12.85% | +6.02% | 95.44B | |
| +6.69% | +11.94% | +57.15% | +306.93% | +720.89% | +788.69% | +201.09% | -27.31% | - | 90.58B | |
| +3.25% | +7.22% | +2.88% | +20.13% | +4.61% | +40.00% | -0.12% | +43.50% | +117.51% | 78.09B | |
| +1.42% | +6.40% | +12.75% | +8.48% | +19.41% | +29.61% | -1.61% | -26.08% | +47.51% | 70.41B | |
| Average | +1.88% | +5.37% | +7.70% | +25.00% | +52.13% | +66.77% | +49.50% | +84.79% | +225.32% | 265.1B | |
| Weighted average by Cap. | +1.48% | +4.97% | +6.78% | +15.70% | +31.71% | +48.91% | +68.18% | +151.68% | +465.81% |
- Stock Market
- Stocks
- GILD Stock
- GILD Stock
- Sector Gilead Sciences, Inc.
Select your edition
All financial news and data tailored to specific country editions
